Search results
Added:
3 months ago
Source:
Arrhythmia Academy
In atrial fibrillation (AF) patients post one-year drug-eluting stent (DES) implantation, non–vitamin K antagonist oral anticoagulant (NOAC) was shown to be noninferior to NOAC plus clopidogrel combination therapy.¹ Current guidelines recommend NOAC monotherapy in this patient population, but supporting evidence has been limited.²MethodologyThe ADAPT AF-DES trial was a multicenter, randomised,…
View more
Could Acute COVID-19 Infection Ignite Thrombotic Risk?
Author(s):
Joshua Stolker
,
Philippe Gabriel Steg
,
Roberta Rossini
,
et al
Added:
1 year ago
Expert Opinion
Factor XIa Inhibitors’ Future Position in AF
Author(s):
Maki Komiyama
,
Moritake Iguchi
,
Hiromichi Wada
,
et al
Added:
1 year ago
Expert Opinion
Anticoagulant Use in Older Adults
Author(s):
Monika Bhandari
,
Akshyaya Pradhan
,
Pravesh Vishwakarma
,
et al
Added:
1 year ago
Review Article
Factor XI Inhibition and AF
Author(s):
Bianca Rocca
,
Hugo ten Cate
Added:
1 year ago
Expert Opinion